Literature DB >> 32279718

Wilson Disease: An Overview and Approach to Management.

Caitlin Mulligan1, Jeff M Bronstein2.   

Abstract

Wilson's disease is one of the few preventable movement disorders in which there are therapies that modify disease progression. This disease is caused by copper overload caused by reduced copper excretion secondary to genetic mutations in the ATP7B gene. Copper overload can lead to a variety of clinical presentations, including neurologic symptoms, liver failure, and/or psychiatric manifestations. There is often a delay in diagnosis of Wilson disease, and awareness of the diagnosis and management is important because of the treatable nature of this condition. This article reviews the clinical presentation, epidemiology, genetics, pathophysiology, diagnosis, and management of Wilson disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chelation; Copper; Movement disorder; Wilson disease

Year:  2020        PMID: 32279718     DOI: 10.1016/j.ncl.2020.01.005

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  15 in total

1.  Disappearance of Clinical and Imaging Manifestations in Wilson's Disease with Ammonium Tetrathiomolybdate and Zinc.

Authors:  Ignacio J Posada; Ana Ramos
Journal:  Mov Disord Clin Pract       Date:  2021-11-10

2.  Pearls & Oy-sters: Challenges and Controversies in Wilson Disease.

Authors:  Marta Ruiz-Lopez; Ana Moreno Estébanez; Beatriz Tijero; Tamara Fernandez; Alba Rebollo-Perez; Iñigo Gabilondo; Nuria Lopez-Osle; Leticia Ceberio-Hualde; Juan Jose Zarranz; Juan Carlos Gomez-Esteban
Journal:  Neurology       Date:  2022-06-13       Impact factor: 11.800

3.  Bilateral Optic Neuropathy as the Prominent Manifestation of Wilson's Disease.

Authors:  Shilin Yang; Shenyi Kuang; Yiqin Xiao; Xiang Han
Journal:  J Clin Neurol       Date:  2022-07       Impact factor: 2.566

4.  Mutation spectrum of ATP7B gene in pediatric patients with Wilson disease in Vietnam.

Authors:  Nguyen Thi Mai Huong; Nguyen Pham Anh Hoa; Ngo Diem Ngoc; Nguyen Thi Phuong Mai; Pham Hai Yen; Hoàng Thị Vân Anh; Giang Hoa; Tran Minh Dien
Journal:  Mol Genet Metab Rep       Date:  2022-03-15

5.  Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease.

Authors:  Grażyna Gromadzka; Diana Wierzbicka; Tomasz Litwin; Adam Przybyłkowski
Journal:  Biometals       Date:  2021-02-08       Impact factor: 2.949

Review 6.  Complex dystonias: an update on diagnosis and care.

Authors:  Rebecca Herzog; Anne Weissbach; Tobias Bäumer; Alexander Münchau
Journal:  J Neural Transm (Vienna)       Date:  2020-11-13       Impact factor: 3.575

7.  Platinum-Based Interdigitated Micro-Electrode Arrays for Reagent-Free Detection of Copper.

Authors:  Robert Daly; Tarun Narayan; Han Shao; Alan O'Riordan; Pierre Lovera
Journal:  Sensors (Basel)       Date:  2021-05-19       Impact factor: 3.576

Review 8.  Hepatocrinology.

Authors:  Sanjay Kalra; Saptarshi Bhattacharya; Pawan Rawal
Journal:  Med Sci (Basel)       Date:  2021-06-01

Review 9.  Review of Hereditary and Acquired Rare Choreas.

Authors:  Daniel Martinez-Ramirez; Ruth H Walker; Mayela Rodríguez-Violante; Emilia M Gatto
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-08-06

10.  Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects.

Authors:  Karl Heinz Weiss; Catherine Thompson; Peter Dogterom; Yi-Jin Chiou; Tim Morley; Brinley Jackson; Naseem Amin; Camille Omar Farouk Kamlin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-08-06       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.